> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Inspection Efficiency Measure Drops
- URL: https://www.fdaweb.com/fda-inspection-efficiency-measure-drops/
- Published: 2022-01-27T12:00:00.000Z
- Updated: 2026-09-14T17:30:15.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151025

FDA says that in FY 2020, the percentage of regulatory actions for OAI (official action indicated) drug manufacturing facilities completed within six months of inspection closing dropped to 63% from 74% in FY 2019\. In both fiscal years, the performance measure for issuing a final facility classification letter within 90 days of inspection closing was 87%.

The performance measures were established under a 2017 Concept of Operations agreement developed by CDER and the Office of Regulatory Affairs to more effectively manage the growing complexity of the pharmaceutical landscape and to meet new challenges.

The FY 2020 [summary](http://www.fda.gov/media/155616/download?ref=fdaweb.com) says that from 3/2020, the Covid-19 pandemic affected the day-to-day operations at FDA and Covid-19 travel restrictions postponed non-mission-critical facility inspections.

Access the FY 2019 summary [here](http://www.fda.gov/media/142229/download?ref=fdaweb.com).